OCC 1.28% 38.5¢ orthocell limited

Ann: Recruitment Complete - Ortho-ATI Shoulder Tendon Study, page-4

  1. 7,576 Posts.
    lightbulb Created with Sketch. 6849
    Still missing their easier TGA CelGro submission deadline. Ironically ATI wasn't strictly penciled for a set 2Q 2020 deadline, though I hoped they'd get it through, roll on initial data (will encourage a bigger move) and partnership release.

    The announcement didn't exactly set the market on fire. If they get a bit of coverage on Australian investment media the stock might drift up over the next few days. At least they finally got ATI recruitment done. This is a big one for me. A partnership with J&J basically will set them up financially for the forthcoming years (no more capital raises unless they are expansionary ones to fund growth projects) and they can start getting ATI in the market properly on stage three trials in the US with J&J and hopefully through normal access via ARTG list inclusion in Australia.

    This trial should have been finished a year ago, but glad its finally done at last.


 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
38.5¢
Change
-0.005(1.28%)
Mkt cap ! $80.59M
Open High Low Value Volume
39.0¢ 39.0¢ 38.0¢ $31.21K 81.11K

Buyers (Bids)

No. Vol. Price($)
4 57705 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 1315 1
View Market Depth
Last trade - 13.37pm 09/08/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.